We provide you with 20 years of free, institutional-grade data for RDY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RDY. Explore the full financial landscape of RDY stock.
| Reported Date | Ticker | Type | |
|---|---|---|---|
| 2026-01-02 | RDY | 6-K | Url |
| 2025-12-31 | RDY | 6-K | Url |
| 2025-12-23 | RDY | 6-K | Url |
| 2025-12-16 | RDY | 6-K | Url |
| 2025-12-16 | RDY | 6-K | Url |
| 2025-12-12 | RDY | 6-K | Url |
| 2025-12-12 | RDY | 6-K | Url |
| 2025-12-10 | RDY | 6-K | Url |
| 2025-12-08 | RDY | 6-K | Url |
| 2025-12-03 | RDY | 6-K | Url |
| 2025-11-28 | RDY | 6-K | Url |
| 2025-11-28 | RDY | 6-K | Url |
| 2025-11-28 | RDY | 6-K | Url |
| 2025-11-25 | RDY | 6-K | Url |
| 2025-11-18 | RDY | 6-K | Url |
| 2025-11-17 | RDY | 6-K | Url |
| 2025-11-17 | RDY | 6-K | Url |
| 2025-11-13 | RDY | 6-K | Url |
| 2025-11-12 | RDY | 6-K | Url |
| 2025-10-31 | RDY | 6-K | Url |
| 2025-10-29 | RDY | 6-K | Url |
| 2025-10-27 | RDY | 6-K | Url |
| 2025-10-27 | RDY | 6-K | Url |
| 2025-10-24 | RDY | 6-K | Url |
| 2025-10-24 | RDY | 6-K | Url |
| 2025-10-24 | RDY | 6-K | Url |
| 2025-10-24 | RDY | 6-K | Url |
| 2025-10-21 | RDY | 6-K | Url |
| 2025-10-14 | RDY | 6-K | Url |
| 2025-09-22 | RDY | 6-K | Url |
| 2025-09-22 | RDY | 6-K | Url |
| 2025-09-19 | RDY | 6-K | Url |
| 2025-09-16 | RDY | 6-K | Url |
| 2025-09-15 | RDY | 6-K | Url |
| 2025-09-15 | RDY | 6-K | Url |
| 2025-09-11 | RDY | 6-K | Url |
| 2025-09-08 | RDY | 6-K | Url |
| 2025-09-04 | RDY | 6-K | Url |
| 2025-09-02 | RDY | 6-K | Url |
| 2025-09-02 | RDY | 6-K | Url |
| 2025-08-29 | RDY | 6-K | Url |
| 2025-08-26 | RDY | 6-K | Url |
| 2025-08-21 | RDY | 6-K | Url |
| 2025-08-13 | RDY | 6-K | Url |
| 2025-08-11 | RDY | 6-K | Url |
| 2025-08-08 | RDY | 6-K | Url |
| 2025-07-30 | RDY | 6-K | Url |
| 2025-07-30 | RDY | 6-K | Url |
| 2025-07-28 | RDY | 6-K | Url |
| 2025-07-25 | RDY | 6-K | Url |
Dr. Reddy's Laboratories Limited(NYSE:RDY) 
Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical...
Website: http://www.drreddys.com
Founded: 1984
Full Time Employees: 21,650
CEO: Erez Israeli
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about RDY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.